Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Salivary Gland Adenoma, Pleomorphic × Isoflavones × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Genitourinary 1

Conditions

Prostatic Neoplasms 4 Hot Flashes 3 Breast Neoplasms 2 Salivary Gland Adenoma, Pleomorphic 1 Recurrence 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1

Interventions

histrelin 1 carfilzomib 1 Urination 1 Soy Milk 1 Isoflavones 1 Gonadotropin-Releasing Hormone 1 Docetaxel 1 Diathermy 1 Dexamethasone 1 Bariatric Surgery 1 Acyclovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00596895 2011-09-20

Isoflavone in Prostate-specific Antigen Recurrent Prostate Cancer

University of Florida

Phase 2 Completed

GenitourinaryHead & Neck

Salivary Gland Adenoma, Pleomorphic, Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡